Sobre 1 señal de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Discover the full record of transactions filed by Duker Jay S., Director General. Director active across 3 companies, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 20 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €17k. History available since 9 February 2022. The latest transaction was filed on 10 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Duker Jay S.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Duker Jay S. is Directeur Général. He is associated with EyePoint Pharmaceuticals, Inc., EyePoint, Inc. and Sesen Bio, Inc. The declarant has 20 filings in total. In the recent sampled filings, the period runs from 2022-02-11 to 2026-07-14, with EUR 17248 of buys and EUR 0 of sells, and the most common transaction nature is Option exercise.